Table 3 Median levels of PIVKA-II and AFP in serum of HCC patients before and after transplantation.

From: Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma

Tumor marker

Sample

Before OLT

1 month after OLT

6 months after OLT

1 year after OLT

2 years after OLT

PIVKA-II (mAU/mL)

 Median

62

23.50

35.50

32.50

32

 IQR

30.75–227.75

14.75–35.75

26.50–37.75

24–41.25

23–53.75

AFP (ng/mL)

 Median

5

1.50

2

2

2

 IQR

2.75–6.25

1–2.50

1–2.75

1–3.25

1–5

  1. OLT orthotopic liver transplant, IQR interquartile range.
Back to article page